Clincosm LogoSign in Get a demo

Music Therapy for Speech and Prosody in Autistic Children (MTSPAC)

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06110884
Collaborator
(none)
40
Enrollment
2
Arms
36
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

This research is a single-blind randomized controlled trial, where the investigators plan to recruit 40 children with autism, randomly divided into two groups. The music therapy intervention group will receive an hour of group music therapy in addition to traditional language therapy. The control group will receive only traditional language therapy. The trial will last for 8 weeks, and participants in both groups will be assessed before and after the trial.

During the study, the investigators will use professional recording equipment to record their speech and use the speech analysis software to objectively compare whether there are significant differences in prosody between the two groups of children with autism before and after the intervention. Besides the acoustic measurement the investigators also assess the language abilities autism trait performance, adaptive function, emotional behavior, and parent-child stress levels.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: music therapy, speech therapy
  • Behavioral: speech therapy
 N/A

Detailed Description

This research is a single-blind randomized controlled trial, where the investigators plan to recruit 40 children with autism, randomly divided into two groups. The music therapy intervention group will receive an hour of group music therapy in addition to traditional language therapy. The control group will receive only traditional language therapy. The trial will last for 8 weeks, and participants in both groups will be assessed before and after the trial.

During the study, the investigators will use professional recording equipment to record their speech and use the speech analysis software to objectively compare whether there are significant differences in prosody between the two groups of children with autism before and after the intervention. Besides the acoustic measurement the investigators also assess the language abilities autism trait performance, adaptive function, emotional behavior, and parent-child stress levels.

The study hypothesizes that music therapy can contribute to improving language development delays in children with autism and may enhance their language development further by ameliorating prosody abnormalities. The investigators hope that this research can propose more diversified therapeutic methods for language development in children with autism.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Music Therapy for Speech Delay and Prosody Disorder in Children With Autism
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Dec 31, 2026
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Music therapy group

Behavioral: music therapy, speech therapy
receive group music therapy in addition to traditional language therapy
Active Comparator: Control group

Behavioral: speech therapy
receive only traditional language therapy

Outcome Measures

Primary Outcome Measures

  1. Revised version of the Preschool Language Scale (PLS) [8 weeks]

    assess the language abilities of children, minimum value 0, maximum value 83, higher scores means a better outcome

  2. Checklist for Autism Spectrum Disorder-Chinese Version (CASD-C) [8 weeks]

    evaluate autism trait performance

Secondary Outcome Measures

  1. Child Behavior Checklist for Ages 1½-5 (CBCL 1½-5) [8 weeks]

    evaluate emotional behavior

  2. Parenting Stress Index [8 weeks]

    evaluate parent-child stress levels, minimum value 36, maximum value 180, higher scores means a worse outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • children with autism

  • aged 3-5 y/o

  • children with speech delay (T-score of Preschool Language Scale < 40)

  • Mandarin as first language

Exclusion Criteria:

  • children with other neurological diseases

  • children without verbal output

  • children with articulation or voice disorder

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • National Taiwan University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT06110884
Other Study ID Numbers:
  • 202307099RIND
First Posted:
Nov 1, 2023
Last Update Posted:
Nov 1, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Speech Disorders
Language Development Disorders

Study Results

No Results Posted as of Nov 1, 2023